Dr. Rafael Gonzalez
speaker
1,275 appearances
2 recordings
2 series
first heard Apr 2026
last heard 30 Jun
Dr. Rafael Gonzalez’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 2 in all, peaking in Jun 2026 with 1.
Appearances
Quite a while.
But our cell therapeutics, our study that's furthest along, we're hoping with good results, because we're in what's called the phase two, three clinical study, transition study, is within the next couple of years, we might have an approval.
Really?
Yeah.
Yeah.
Yes, we are because we're seeing a phenomenal safety profile, no adverse events, which is fantastic, which is rare.
And we're seeing some really good clinical benefit where I found an angel many, many years ago that helped fund this entire study.
She suffered from the disease.
She's actually seen at Brigham and Women's Hospital in Boston.
And she's in remission of disease now for four years, which she was in bad shape when I first met her.
Off of all her meds, immunosuppressants, all of that with this particular type of autoimmune disease.
So we're getting some promising things in the context of cell therapeutics.
And acetylcysteine, I think it's beyond important because it helps clear oxidative stress.
Okay, good.
I take that.
Okay.
I take that too.
Yes.
It's one of the biggest important ones.
It's crazy because you OD on what we just talked about, Tylenol or ibuprofen, you go to the hospital, this is what they're going to give you.
Showing 521–540 of 1,275 · page 27 of 64
← Previous
Next →